Literature DB >> 19953671

Flow cytometry-based methods for assessing soluble scFv activities and detecting antigens in solution.

Sean A Gray1, Kris M Weigel, Keith D Miller, Joseph Ndung'u, Philippe Büscher, Thao Tran, Cheryl Baird, Gerard A Cangelosi.   

Abstract

Novel methods are reported for evaluating and utilizing single chain fragment variable (scFv) antibodies derived from yeast-display libraries. Yeast-display was used to select scFv specific to invariant surface glycoproteins (ISG) of Trypanosoma brucei. A limiting step in the isolation of scFv from non-immune libraries is the conversion of highly active yeast-displayed scFv into soluble antibodies that can be used in standard immunoassays. Challenges include limited solubility or activity following secretion and purification of scFv. For this reason, few scFv derived from yeast-display platforms have moved into development and implementation as diagnostic reagents. To address this problem, assays were developed that employ both yeast-displayed and -secreted scFv as analytical reagents. The first is a competitive inhibition flow cytometry (CIFC) assay that detects secreted scFv by virtue of their ability to competitively inhibit the binding of biotinylated antigen to yeast-displayed scFv. The second is an epitope binning assay that uses secreted scFv to identify additional yeast-displayed scFv that bind non-overlapping or non-competing epitopes on an antigen. The epitope binning assay was used not only to identify sandwich assay pairs with yeast-displayed scFv, but also to identify active soluble scFv present in low concentration in a crude expression extract. Finally, a CIFC assay was developed that bypasses entirely the need for soluble scFv expression, by using yeast-displayed scFv to detect unlabeled antigen in samples. These methods will facilitate the continued development and practical implementation of scFv derived from yeast-display libraries. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19953671      PMCID: PMC2851250          DOI: 10.1002/bit.22607

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  32 in total

Review 1.  Application of aptamers in therapeutics and for small-molecule detection.

Authors:  M Menger; J Glökler; M Rimmele
Journal:  Handb Exp Pharmacol       Date:  2006

Review 2.  RNA aptamers as potential pharmaceuticals against infections with African trypanosomes.

Authors:  H U Göringer; M Homann; M Zacharias; A Adler
Journal:  Handb Exp Pharmacol       Date:  2006

3.  The invariant surface glycoprotein ISG75 gene family consists of two main groups in the Trypanozoon subgenus.

Authors:  T Tran; F Claes; J C Dujardin; P Buscher
Journal:  Parasitology       Date:  2006-09-04       Impact factor: 3.234

4.  Increasing the secretory capacity of Saccharomyces cerevisiae for production of single-chain antibody fragments.

Authors:  E V Shusta; R T Raines; A Plückthun; K D Wittrup
Journal:  Nat Biotechnol       Date:  1998-08       Impact factor: 54.908

5.  The use of scFv-displaying yeast in mammalian cell surface selections.

Authors:  Xin Xiang Wang; Eric V Shusta
Journal:  J Immunol Methods       Date:  2005-09       Impact factor: 2.303

6.  A flow cytometric assay for screening improved heterologous protein secretion in yeast.

Authors:  J Andy Rakestraw; Angelin R Baskaran; K Dane Wittrup
Journal:  Biotechnol Prog       Date:  2006 Jul-Aug

7.  Thioredoxin fusions increase folding of single chain Fv antibodies in the cytoplasm of Escherichia coli: evidence that chaperone activity is the prime effect of thioredoxin.

Authors:  Paola Jurado; Víctor de Lorenzo; Luis A Fernández
Journal:  J Mol Biol       Date:  2006-01-06       Impact factor: 5.469

8.  Serum-stable RNA aptamers to an invariant surface domain of live African trypanosomes.

Authors:  Matthias Homann; Mihaela Lorger; Markus Engstler; Martin Zacharias; H Ulrich Göringer
Journal:  Comb Chem High Throughput Screen       Date:  2006-08       Impact factor: 1.339

9.  Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.

Authors:  Toya Nath Baral; Stefan Magez; Benoît Stijlemans; Katja Conrath; Benoit Vanhollebeke; Etienne Pays; Serge Muyldermans; Patrick De Baetselier
Journal:  Nat Med       Date:  2006-04-09       Impact factor: 53.440

10.  A Mycobacterium tuberculosis gene cluster encoding proteins of a phosphate transporter homologous to the Escherichia coli Pst system.

Authors:  M Braibant; P Lefèvre; L de Wit; P Peirs; J Ooms; K Huygen; A B Andersen; J Content
Journal:  Gene       Date:  1996-10-17       Impact factor: 3.688

View more
  3 in total

1.  Synergistic capture of Clostridium botulinum type A neurotoxin by scFv antibodies to novel epitopes.

Authors:  Sean A Gray; John R Barr; Suzanne R Kalb; James D Marks; Cheryl L Baird; Gerard A Cangelosi; Keith D Miller; Michael J Feldhaus
Journal:  Biotechnol Bioeng       Date:  2011-05-12       Impact factor: 4.530

2.  Methodology for preservation of yeast-bound single chain fragment variable antibody affinity reagents.

Authors:  Maria Kahn; Scott Priddy; Marcus Estrada; Lauren Spadafora; Gerard A Cangelosi; Gonzalo J Domingo
Journal:  J Immunol Methods       Date:  2015-11-10       Impact factor: 2.303

3.  Toward low-cost affinity reagents: lyophilized yeast-scFv probes specific for pathogen antigens.

Authors:  Sean A Gray; Kris M Weigel; Ibne K M Ali; Annie A Lakey; Jeremy Capalungan; Gonzalo J Domingo; Gerard A Cangelosi
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.